Lively discussion going on in Twitter world about yesterday's results. Some, ie Adam Feuerstein and others who claim to "experts" in Biotech see no reason for yesterday's PR from Astex and subsequent stock runup. Others ie analysts from RBC and JMP love the news and reaffirmed higher price targets. Who to believe???
I expected the information release at the next conference. They must be doing something that requires public release -- i.e. a government filing. There isn't any advantage to the company of a runup now vs the end of September.
Well to me it is a simple answer. The pipeline has and will strengthen over time. We are moving closer to a payday with each passing month. Those who wish to play the short game are at a larger risk than before on this stock. The risk is on the short side since “events” like the one we just experienced will happen with more frequency on SGI-110 and other compounds in the pipeline.
Lots of positive things ready to harvest.
To those who wish to short and think otherwise; you are going to get burned, this is not your daddy’s stock anymore.
Astex will not and should not market S110. I believe they will either be bought out or partner with Eiasi and JNJ for rights. This might come sooner than later. A deal would give them a Big bump in cash and limited furure burn. They want to get the best deal they can. Playing hardball.